Osaka
Sun, Sep. 05 2010
10:39 PM
Chicago
Sun, Sep. 05 2010
08:39 AM
Home
Business
Osaka as a Hub
Business Then and Now
Efficient Location
Industry Concentration
Convention in Osaka
Cost and Quality
Living in Osaka
Start Business in Osaka
Priority Industries
Information Technology
Robotics
Bio and Health
Environment
Case Studies
Case A
Case B - Hospira
Case C
Business Links
Business Inquiry Form
Visit Osaka
Historic Past
Festivals
Traditional Arts
Bunraku 2007
Food
Modern Highlights
Model Courses
Tour Tips
Tour Links
Tour Inquiry Form
City of Osaka
Facts
History
Sister Cities
Chicago
Osaka Garden
Sister School
San Francisco
Chicago Office
News
Events
Newsletter Archive
Contact Us
Links
Business Links
Tour Links
News
Events
Newsletter Archive
Contact Us
News
SENILE PLAQUES WERE CONFIRMED TO BE NOT THE CAUSE OF ALZHEIMER’S DISEASE
6/2/2010
Kippo News from Wednesday, May 19, 2010
Osaka City University professors Takami Tomiyama and Hiroshi Mori and their colleagues confirmed in mice experiments that Alzheimer’s disease is caused simply when amyloid beta oligomers, small aggregates of a protein called amyloid beta, accumulate in the brain. The study was published in the U.S. scientific journal The Journal of Neuroscience (electronic edition).
It has been widely accepted that Alzheimer’s disease occurs and progresses due to accumulation of amyloid beta. However, opinions were divided as to whether the exact cause was senile plaques, large accumulations of amyloid beta that look like flecks, or amyloid beta oligomers.
The research team discovered in an Alzheimer’s patient a mutant-type amyloid beta that only forms amyloid beta oligomers. Subsequently, the researchers successfully created a mouse that has the mutant-type amyloid beta. Consequently, it was confirmed that Alzheimer’s disease occurs and progresses simply due to accumulation of amyloid beta oligomers. Accordingly, it was confirmed that senile plaques are not the cause of the disease. Osaka City University says it intends to engage in development of diagnostic techniques and therapeutic drugs targeting amyloid beta oligomers.
Contact:
Department of Neuroscience Graduate School of Medicine, Osaka City University
(site mostly in Japanese)
TEL:06-6645-3921
> Back to Index